KOLKATA, NOVEMBER 25TH, 2024 - Strides Pharma Science, a midcap pharmaceutical company, witnessed a sharp decline in its stock price on November 25th, 2024, plummeting by 5.71% amid the sector's underperformance. According to MarketsMOJO, Strides Pharma Science remains a 'Hold' rated stock and has been included in their Momentumnow